• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Akanda Corp. (Amendment)

    2/20/24 12:55:32 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AKAN alert in real time by email
    SC 13G/A 1 sc13ga.htm AMENDMENT NO. 1 TO SCHEDULE 13G

    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

     

    Amendment No. 1 to
    SCHEDULE 13G



    INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    AKANDA CORP.
    (Name of Issuer)




    Common Shares, no par value
    (Title of Class of Securities)



    00971M205
    (CUSIP Number)


    May 27, 2023
    (Date of Event Which Requires Filing of This Statement)


    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:


                     Rule 13d-1(b)
                Rule 13d-1(c)
            X    Rule 13d-1(d)




    1
    NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
     
     
    Halo Collective Inc.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)
    (b)
     
         
    3
    SEC USE ONLY
     
         
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Ontario, Canada
     
    5
    SOLE VOTING POWER
    NUMBER OF
     
    0
    SHARES
    6
    SHARED VOTING POWER
    BENEFICIALLY
     
    0
    OWNED BY
    7
    SOLE DISPOSITIVE POWER
    EACH
     
    0
    REPORTING
    8
    SHARED DISPOSITIVE POWER
    PERSON WITH
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    0
     
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 
     
         
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    0%
     
    12
    TYPE OF REPORTING PERSON*
     
    CO
    *SEE INSTRUCTIONS BEFORE FILLING OUT!


    Item 1 (a). Name of Issuer:

    Akanda Corp.

    Item 1 (b). Address of Issuer’s Principal Executive Offices:

    1a, 1b Learoyd Road
    New Romney TN28 8XU United Kingdom

    Item 2 (a). Name of Person Filing:

    Halo Collective Inc.

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

    65 Queen Street West, Suite 815
    Toronto, Ontario M5H 2M5 Canada

    Item 2 (c). Citizenship:

    Ontario, Canada

    Item 2 (d). Title of Class of Securities:

    Common Shares, no par value

    Item 2 (e). CUSIP Number:

    00971M205

    Item 3.
    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

    (a)
    Broker or dealer registered under Section 15 of the Act;


    (b)
    Bank as defined in Section 3(a)(6) of the Act;


    (c)
    Insurance Company as defined in Section 3(a)(19) of the Act;


    (d)
    Investment Company registered under Section 8 of the Investment Company Act;


    (e)
    Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);


    (f)
    Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);


    (g)
    Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);


    (h)
    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

    (i)
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940:


    (j)
    Group, in accordance with Rule 13d-1(b)(1)(ii)(j).

    If this statement is filed pursuant to Rule 13d-1(c), check this box.

    Item 4.
    Ownership.

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.


    (a)
    Amount beneficially owned:

    0


    (b)
    Percent of class:

    0%


    (b)
    Number of shares as to which such person has:

    (i)
    Sole power to vote or to direct the vote:  0


    (ii)  Shared power to vote or to direct the vote:  0

    (iii)  Sole power to dispose or to direct the disposition of:  0

    (iv)  Shared power to dispose or to direct the disposition of:   0


    Instruction.  For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1).

    Item 5.
    Ownership of Five Percent or Less of a Class.

    If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  X  ].


    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.

    N/A

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

    N/A

    Item 8.
    Identification and Classification of Members of the Group.

    N/A

    Item 9.
    Notice of Dissolution of Group.

    N/A



    Item 10. Certification.



    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.



     
    February 16, 2024
     
    (Date)
     
    HALO COLLECTIVE INC.
    By:  /s/ Katie Field
           Katie Field, Chairman & CEO
     
    Get the next $AKAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AKAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AKAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Univest Securities, LLC Announces Closing of $5 Million Underwritten Public Offering for its Client Akanda Corp. (NASDAQ: AKAN)

      New York, March 27, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of underwritten public offering (the "Offering") of 3,087,443 common stock priced at $0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares with respect to the underwritten public offering for its client Akanda Corp. (NASDAQ:AKAN) ("Akanda" or the "Company"), an international medical cannabis company. Under the terms of the securities purchase agreement, the Company has agreed to sell to the institutional investors a total of 3,087,443 sh

      3/27/24 4:45:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility

      International medical cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN, WKN: A3DG83))) announces that Akanda (the "Optionee" the "Company") and 1107385 B.C. LTD (the "Owner") have agreed upon terms to purchase farming land and related operations and licenses. The key deal terms are as follows: Akanda will issue a non-refundable payment equal to One Million Eight Hundred Thousand United States Dollars (USD1,800,000) and if paid in common shares of Akanda will be based on formula to calculate the per share price as set forth in the agreement. The initial payment will be broken up into the First Option Payment, the Second Option Payment and the Third Option Payment, u

      9/20/23 9:00:00 AM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

      International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN) today announced that the Company has received a written notification (the "Notification Letter") on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that the closing bid price of the Company's common shares, no par value ("Common Shares"), was below $1.00 per share for a period of 30 consecutive business days. The Notification Letter does not impact the Company's listing on the

      7/6/23 4:18:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Akanda Corp. (Amendment)

      SC 13D/A - AKANDA CORP. (0001888014) (Subject)

      2/20/24 6:01:03 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Akanda Corp.

      SC 13D - AKANDA CORP. (0001888014) (Subject)

      2/20/24 5:17:13 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Akanda Corp. (Amendment)

      SC 13G/A - AKANDA CORP. (0001888014) (Subject)

      2/20/24 12:55:32 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Financials

    Live finance-specific insights

    See more

    $AKAN
    SEC Filings

    See more
    • Halo Collective Completes Acquisition of Premium Indoor Grow and Distribution Hub in Portland, Oregon

      TORONTO, Sept. 22, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced, further to its press release dated August 27, 2021, that it has completed the acquisition of all of the substantial assets of three operating entities doing business as Pistil Point in Oregon which collectively hold multiple cannabis licenses. With this transaction, Halo now has full ownership of a range of indoor and outdoor cultivation, manufacturing, and distributions assets, along with an expanded library of genetics that is expected to allow the Company to continue to execute its vertically integrated strategy in Oregon with enhanced compet

      9/22/22 5:00:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Halo Collective Announces Westwood Dispensary Completion, Local Inspections Passed, and Planned Opening for Second Budega™ in California

      TORONTO, April 12, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced that its Budega Westwood Dispensary passed its Los Angeles inspection and is expected to open within 30 days. The Budega Westwood location is perfectly located nestled in between Westwood to the west and Beverly Hills to the east, right off of one of LA's most traveled and famous thoroughfares for locals and visitors, the Santa Monica Boulevard (10461 Santa Monica Blvd) and within two miles of the University of Los Angeles California campus. The facility is leased and near complete with renovations of its approximately 1,500 square foot prime retail

      4/12/22 4:40:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by Akanda Corp.

      6-K - AKANDA CORP. (0001888014) (Filer)

      5/1/25 5:00:02 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 20-F filed by Akanda Corp.

      20-F - AKANDA CORP. (0001888014) (Filer)

      4/30/25 3:00:22 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by Akanda Corp.

      6-K - AKANDA CORP. (0001888014) (Filer)

      4/18/25 1:46:03 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Leadership Updates

    Live Leadership Updates

    See more
    • Halo Collective Announces Change of Auditors and Failure to File Cease Trade Order

      Toronto, Ontario--(Newsfile Corp. - June 22, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB:HCANF) (FSE: A9K0) ("Halo" or the "Company") announces today that it has changed its auditor (the "Change of Auditor") from Macias Gini & O'Connell LLP (the "Former Auditor") to GreenGrowth CPAs (the "Successor Auditor"). The Former Auditor resigned effective June 19, 2023, and the Company's board of directors, upon the audit committee's recommendation, appointed the Successor Auditor to fill the resulting vacancy until the close of the next annual meeting of the Company's shareholders.There was no modified opinion, or other opinion, issued by the Former Auditor in connection with its audit of the Co

      6/22/23 1:06:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director

      International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN) today announced its subsidiary Canmart Ltd. brought Tejinder Virk's Service Agreement dated June 2, 2021 (the "Service Agreement") to an immediate end with effect from February 13th, 2023. As disclosed on February 7th, 2023, the Company disclosed Mr. Virk's attempt to end the Service Agreement without providing the requisite period of notice required under the Service Agreement, his interpretation of the Service Agreement, and allegations of Breach of Contract. On February 13th, 2023, the Company informed Mr. Virk that it had reached the conclusion that it has a right to bring the Service

      2/16/23 5:05:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • /R E P E A T -- Halo Collective Appoints Katie Field as Chairman of the Board/

      TORONTO, Aug. 12, 2022 /PRNewswire/ -  Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced the appointment of Katie Field, Chief Executive Officer of Halo, to Chairman of the board of directors of the Company (the "Board"), effective immediately. Current Chairman Ryan Kunkel has resigned from the Board to focus on other professional endeavors. To the knowledge of the Company, Ms. Field is the second woman to serve as Chairman and CEO of a publicly traded cannabis company, the first being Kim Rivers of Trulieve (CSE:TRUL). Ca

      8/12/22 8:00:00 AM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care